• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B 淋巴细胞在代谢相关脂肪性肝病中的多效性作用。

The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease.

机构信息

Department of Pharmacology, University Medical Center, Johannes Gutenberg University, Mainz, Germany.

出版信息

Front Immunol. 2024 Sep 20;15:1447391. doi: 10.3389/fimmu.2024.1447391. eCollection 2024.

DOI:10.3389/fimmu.2024.1447391
PMID:39372417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11449700/
Abstract

Recent evidence suggests that adaptive immune cells are important contributors to metabolic dysfunction-associated steatotic liver disease (MASLD, formerly non-alcoholic fatty liver disease, NAFLD). In liver biopsies from MASLD patients, the accumulation of intrahepatic B cells is positively correlated with the MASLD activity score. Hepatic B-cell infiltration is observed in experimental models of metabolic dysfunction-associated steatohepatitis (MASH, formerly non-alcoholic steatohepatitis, NASH). Intrahepatic B2 cells have been shown to contribute to MASLD/MASH by activating T cells, macrophages and hepatic stellate cells, and by producing pathogenic IgG antibodies. In mice fed a MASH diet, selective depletion of B2 cells reduces steatohepatitis and fibrosis. Intestinal B cells are metabolically activated in MASH and promote T-cell activation independently of TCR signaling. In addition, B cells have been shown to contribute to liver fibrosis by activating monocyte-derived macrophages through the secretion of IgA immunoglobulins. Furthermore, our recent study indicates that certain B cell subsets, very likely regulatory B cells, may play a protective role in MASLD. This review summarizes the molecular mechanisms of B cell functions and discusses future research directions on the different roles of B cells in MASLD and MASH.

摘要

最近的证据表明,适应性免疫细胞是代谢功能障碍相关脂肪性肝病(MASLD,以前称为非酒精性脂肪性肝病,NAFLD)的重要贡献者。在 MASLD 患者的肝活检中,肝内 B 细胞的积累与 MASLD 活动评分呈正相关。在代谢功能障碍相关脂肪性肝炎(MASH,以前称为非酒精性脂肪性肝炎,NASH)的实验模型中观察到肝内 B 细胞浸润。肝内 B2 细胞通过激活 T 细胞、巨噬细胞和肝星状细胞以及产生致病性 IgG 抗体,有助于 MASLD/MASH。在接受 MASH 饮食的小鼠中,选择性耗尽 B2 细胞可减少脂肪性肝炎和纤维化。MASH 中肠道 B 细胞被代谢激活,并通过 TCR 信号独立促进 T 细胞激活。此外,B 细胞通过分泌 IgA 免疫球蛋白激活单核细胞衍生的巨噬细胞,从而有助于肝纤维化。此外,我们最近的研究表明,某些 B 细胞亚群(很可能是调节性 B 细胞)可能在 MASLD 中发挥保护作用。本综述总结了 B 细胞功能的分子机制,并讨论了 B 细胞在 MASLD 和 MASH 中不同作用的未来研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a472/11449700/d48b4698dc0d/fimmu-15-1447391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a472/11449700/d48b4698dc0d/fimmu-15-1447391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a472/11449700/d48b4698dc0d/fimmu-15-1447391-g001.jpg

相似文献

1
The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease.B 淋巴细胞在代谢相关脂肪性肝病中的多效性作用。
Front Immunol. 2024 Sep 20;15:1447391. doi: 10.3389/fimmu.2024.1447391. eCollection 2024.
2
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review.非酒精性脂肪性肝病(MASLD)/非酒精性脂肪性肝炎(MASH):是否有必要进行标记?全面的叙述性综述。
Int J Mol Sci. 2024 Aug 2;25(15):8462. doi: 10.3390/ijms25158462.
3
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.代谢功能障碍相关脂肪性肝病(MASLD)和代谢功能障碍相关脂肪性肝炎(MASH)对心脏、肌肉和肾脏相关疾病的全身影响。
Front Cell Dev Biol. 2024 Jul 16;12:1433857. doi: 10.3389/fcell.2024.1433857. eCollection 2024.
4
Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.基于性别的差异,自然杀伤 T 细胞在保护 Balb/c 小鼠抵抗饮食诱导的脂肪性肝炎中的作用。
Biol Sex Differ. 2023 Nov 14;14(1):85. doi: 10.1186/s13293-023-00569-w.
5
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.富含组氨酸糖蛋白在代谢功能障碍相关脂肪性肝炎相关疾病进展及肝癌发生中的作用
Front Immunol. 2024 Feb 26;15:1342404. doi: 10.3389/fimmu.2024.1342404. eCollection 2024.
6
The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis.多成分药物复合肝制剂在链脲佐菌素和高脂饮食诱导的代谢功能障碍相关脂肪性肝病/代谢功能障碍相关脂肪性肝炎模型中可减轻肝脏炎症和纤维化。
Biomedicines. 2023 Dec 4;11(12):3216. doi: 10.3390/biomedicines11123216.
7
FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis.纤维扫描天门冬氨酸转氨酶:诊断高危代谢功能障碍相关脂肪性肝炎的一种更优的非侵入性模型。
World J Gastroenterol. 2024 May 14;30(18):2440-2453. doi: 10.3748/wjg.v30.i18.2440.
8
Targeting EFHD2 inhibits interferon-γ signaling and ameliorates non-alcoholic steatohepatitis.靶向 EFHD2 抑制干扰素-γ 信号转导并改善非酒精性脂肪性肝炎。
J Hepatol. 2024 Sep;81(3):389-403. doi: 10.1016/j.jhep.2024.04.009. Epub 2024 Apr 25.
9
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD).B2 淋巴细胞对氧化应激衍生抗原的反应有助于非酒精性脂肪性肝病(NAFLD)的发展。
Free Radic Biol Med. 2018 Aug 20;124:249-259. doi: 10.1016/j.freeradbiomed.2018.06.015. Epub 2018 Jun 18.
10
Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10.通过抑制肝 N-乙酰基转移酶 10 改善 MASLD 和 MASH。
Mol Metab. 2024 Nov;89:102030. doi: 10.1016/j.molmet.2024.102030. Epub 2024 Sep 16.

引用本文的文献

1
Biomarker Discovery for Metabolic Dysfunction-associated Steatotic Liver Disease Utilizing Mendelian Randomization, Machine Learning, and External Validation.利用孟德尔随机化、机器学习和外部验证发现代谢功能障碍相关脂肪性肝病的生物标志物
J Clin Transl Hepatol. 2025 Sep 28;13(9):723-733. doi: 10.14218/JCTH.2025.00270. Epub 2025 Jul 16.
2
Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis.肝星状细胞与肝脏微环境之间的动态串扰:肝脏纤维化调控中的多细胞相互作用
Front Cell Dev Biol. 2025 Jul 21;13:1635763. doi: 10.3389/fcell.2025.1635763. eCollection 2025.
3

本文引用的文献

1
Diversity of group 1 innate lymphoid cells in human tissues.人类组织中 I 型固有淋巴细胞的多样性。
Nat Immunol. 2024 Aug;25(8):1460-1473. doi: 10.1038/s41590-024-01885-y. Epub 2024 Jul 2.
2
Roles of innate lymphoid cells in metabolic and alcohol-associated liver diseases.天然淋巴细胞在代谢性和酒精相关性肝病中的作用。
JHEP Rep. 2023 Nov 11;6(2):100962. doi: 10.1016/j.jhepr.2023.100962. eCollection 2024 Feb.
3
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.代谢相关脂肪性肝病中双向免疫交叉对话。
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis.
代谢性和病毒性肝纤维化中B细胞活化的独特生物标志物谱
Int J Mol Sci. 2025 Jun 20;26(13):5942. doi: 10.3390/ijms26135942.
4
Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma.代谢功能障碍相关脂肪性肝病进展中的慢性炎症与免疫失调:从脂肪变性到肝细胞癌
Biomedicines. 2025 May 21;13(5):1260. doi: 10.3390/biomedicines13051260.
5
Transcriptomic and lipidomic analysis of aging-associated inflammatory signature in mouse liver.小鼠肝脏衰老相关炎症特征的转录组学和脂质组学分析
Inflamm Regen. 2025 May 3;45(1):13. doi: 10.1186/s41232-025-00377-2.
6
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).结直肠癌肝转移的发病机制、诊断及临床治疗方法(综述)
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5728. Epub 2025 Feb 14.
7
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017-2020.全身炎症生物标志物与代谢功能障碍相关脂肪性肝病之间的关联:一项2017 - 2020年美国国家健康与营养检查调查(NHANES)的横断面研究
BMC Gastroenterol. 2025 Jan 29;25(1):42. doi: 10.1186/s12876-025-03625-4.
Cell Metab. 2023 Nov 7;35(11):1852-1871. doi: 10.1016/j.cmet.2023.10.009.
4
The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions.IL-10 的多效性:调节、在免疫稳态中的作用及其与癌症、COVID-19 和新冠后状况的相关性。
Front Immunol. 2023 Jun 8;14:1161067. doi: 10.3389/fimmu.2023.1161067. eCollection 2023.
5
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.肠 B 细胞在 NASH 微生物群/抗原非依赖性条件下许可代谢性 T 细胞激活,并通过 IgA-FcR 信号传导促进纤维化。
J Hepatol. 2023 Aug;79(2):296-313. doi: 10.1016/j.jhep.2023.04.037. Epub 2023 May 22.
6
Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis.B 细胞激活因子在非酒精性脂肪性肝炎小鼠模型纤维化进展中的作用。
Int J Mol Sci. 2023 Jan 28;24(3):2509. doi: 10.3390/ijms24032509.
7
Single-cell RNA sequencing identifies a population of human liver-type ILC1s.单细胞 RNA 测序鉴定出一群人肝 ILC1 细胞。
Cell Rep. 2023 Jan 31;42(1):111937. doi: 10.1016/j.celrep.2022.111937. Epub 2023 Jan 1.
8
Role of B Lymphocytes in the Pathogenesis of NAFLD: A 2022 Update.B淋巴细胞在非酒精性脂肪性肝病发病机制中的作用:2022年最新进展
Int J Mol Sci. 2022 Oct 16;23(20):12376. doi: 10.3390/ijms232012376.
9
Cytokine production by human B cells: role in health and autoimmune disease.人类 B 细胞产生细胞因子:在健康和自身免疫性疾病中的作用。
Clin Exp Immunol. 2022 Dec 31;210(3):253-262. doi: 10.1093/cei/uxac090.
10
Role of B cells as antigen presenting cells.B 细胞作为抗原呈递细胞的作用。
Front Immunol. 2022 Sep 8;13:954936. doi: 10.3389/fimmu.2022.954936. eCollection 2022.